A randomized phase II trial of hydroxyurea ± imatinib in the treatment of recurrent or progressive meningiomas

被引：0
|
作者：
Mazza, E. [1 ]
Reni, M. [1 ]
Lombardi, G. [2 ]
Eoli, M. [3 ]
Franceschi, E. [4 ]
Faedi, M. [5 ]
Fugazza, C. [1 ]
Maggiora, P. [1 ]
Finocchiaro, G. [3 ]
Brandes, A. [4 ]
机构：
[1] Hosp San Raffaele, I-20132 Milan, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy
[4] Bellaria Maggiore Hosp, Bologna, Italy
[5] Osped Gen Provinciale M Bufalini, Cesena, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3356
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [1] Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
    Mazza, Elena
    Brandes, Alba
    Zanon, Silvia
    Eoli, Marika
    Lombardi, Giuseppe
    Faedi, Marina
    Franceschi, Enrico
    Reni, Michele
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (01) : 115 - 120
  • [2] Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
    Elena Mazza
    Alba Brandes
    Silvia Zanon
    Marika Eoli
    Giuseppe Lombardi
    Marina Faedi
    Enrico Franceschi
    Michele Reni
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 77 : 115 - 120
  • [3] Phase II trial of imatinib mesylate (GLEEVEC) and hydroxyurea for adults with recurrent/progressive meningioma
    Goli, Krishna
    Bota, Daniela
    Desjardins, Annick
    Rich, Jeremy
    Vredenburgh, James
    Quinn, Jennifer
    Sathornsumetee, Sith
    Salvado, August
    Friedman, Henry
    Reardon, David
    [J]. NEURO-ONCOLOGY, 2007, 9 (04) : 519 - 519
  • [4] Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma
    Bota, D. A.
    Desjardins, A.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Sathornsumetee, S.
    Goli, K.
    Salvado, A.
    Friedman, H. S.
    Reardon, D. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] A phase II trial of PTK-787 (PTK/ZK) in recurrent or progressive meningiomas
    DeBoer, R.
    Grimm, S. A.
    Chandler, J.
    Gallot, L.
    Kennedy, S.
    Burns, K.
    Rice, L.
    Cabreza, C.
    Muro, K.
    Raizer, J. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Phase II trial of imatinib mesylate plus hydroxyurea in the treatment of patients with malignant glioma
    Reardon, D
    Friedman, A
    Herndon, J
    Quinn, J
    Rich, J
    Vredenburgh, J
    Badruddoja, M
    Desjardins, A
    Sampson, J
    Gururangan, S
    Dowell, J
    Affronti, M
    Allen, D
    Jackson, S
    Zeigler, K
    Silverman, S
    Tourt-Uhlig, S
    Silverman, S
    Salvado, A
    Nikolova, Z
    Bigner, D
    Friedman, H
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 381 - 381
  • [7] Treatment of high risk or recurrent meningiomas with hydroxyurea
    Rosenthal, MA
    Ashley, DL
    Cher, L
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2002, 9 (02) : 156 - 158
  • [8] Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
    Reardon, D. A.
    Dresemann, G.
    Taillibert, S.
    Campone, M.
    van den Bent, M.
    Clement, P.
    Blomquist, E.
    Gordower, L.
    Schultz, H.
    Raizer, J.
    Hau, P.
    Easaw, J.
    Gil, M.
    Tonn, J.
    Gijtenbeek, A.
    Schlegel, U.
    Bergstrom, P.
    Green, S.
    Weir, A.
    Nikolova, Z.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (12) : 1995 - 2004
  • [9] Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
    D A Reardon
    G Dresemann
    S Taillibert
    M Campone
    M van den Bent
    P Clement
    E Blomquist
    L Gordower
    H Schultz
    J Raizer
    P Hau
    J Easaw
    M Gil
    J Tonn
    A Gijtenbeek
    U Schlegel
    P Bergstrom
    S Green
    A Weir
    Z Nikolova
    [J]. British Journal of Cancer, 2009, 101 : 1995 - 2004
  • [10] Imatinib mesylate plus hydroxyurea for adults with recurrent/progressive low-grade glioma: Final phase II study results
    Peters, K.
    Desjardins, A.
    Vredenburgh, J. J.
    Dryman, B.
    Gururangan, S.
    Friedman, H. S.
    Reardon, D. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345